Ebola outbreaks are sporadic and usually confined to the continent of Africa so the virus is not seen as a priority for most pharmaceutical companies. Because of the worst ever Ebola outbreak in history, drug manufacturers are not shifting focus and are trying to test medication so that a cure can be found.
The options that are discussed include experimental treatments. They have never been tested on people. There are also treatment options that include Lipitor and statins, mainly used to lower cholesterol, as it is said to help in dealing with the virus.
Smaller pharmaceutical companies are the most active at the moment in looking for a cure, mainly because they would receive government funding.
There is also a growth noticed in the interest in investors. Companies of interest that might receive extra government funding for performing Ebola medication tests include BioCryst Pharmaceuticals.
According to experts, many of the drugs are in an early development stage. It is said that they cannot make a difference since they are available just in really limited quantities.
Initial human tests may start next month with healthy volunteers. It was announced that some may be health care workers that want to go to Africa to help deal with the outbreak.